A disorder caused by a lack of blood flow or gas exchange to or from the fetus in the period immediately before, during, or after the birth process.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Argenica Therapeutics Ltd.
Other
Domp farmaceutici S.p.A.
Other
ESPL Regulatory Consulting Limited
Other
Fera Pharmaceuticals, LLC
Other
Jazz Pharmaceuticals Research UK Limited
Other
Medinno Inc.
Other
Mithra Pharmaceuticals S.A.
Other
Neurophyxia B.V.
Other
Neuroprotexeon
Other
Nour Heart Therapeutics, LLC
Other
PuREC Co., Ltd.
Other
ReAlta Life Sciences, Inc.
Other
Scharper S.p.A.
Other
WORPHMED Srl
Other
Wanbangde Pharmaceutical Group Co, Ltd.
Other